8:30AM – 9/30/2014: Future of Specialty Pharma in Europe @14th Global Partnering & Biotech Investment, Congress Center Basel – SACHS Associates, London
Real Time Media Conference Coverage – Business and Scientific Channels: Aviva Lev-Ari, PhD, RN @ http://pharmaceuticalintelligence.com
8:20AM – Welcome Speech by Beth Jacobs, Managing Partner, Excellentia Global Partners
First event in Basel. Biotech busy year for VCs, Alibaba was the largest IPO on Wall Street, $231Billion valuation, NYT $300Millions in Fees for underwriters. Regulatory filings new requirements. Trends may continue in public and private fundings to enable bringing cure to the bedside.
Biotech ecosystem will continue to growth allowing for new business opportunities
8:30AM – Future of Specialty Pharma in Europe
Panelists:
- Nicholas Franco, Executive Vice President & Chief Business Development Officer, Actelion
#startup#biotech
#pharmanews |
@SachsAssociates@pharma_BI
@BiotechNews |
Leave a Reply